share_log

5 Penny Stocks Insiders Are Buying

5 Penny Stocks Insiders Are Buying

內部人士正在買入5只細價股
Benzinga Real-time News ·  2022/01/18 06:50

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

當內部人士買賣股票時,這表明了他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易員可以在他們的整體投資或交易決策中考慮這一因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是最近幾筆值得注意的細價股內幕交易。欲瞭解更多資訊,請查看Benzinga的內幕交易平臺。

Liberty Star Uranium & Metals

自由之星鈾金屬公司

  • The Trade: Liberty Star Uranium & Metals Corp. (OTC:LBSR) President and CEO Brett Gross acquired a total of 1395379 shares at an average price of $0.27. To acquire these shares, it cost $375,356.95.
  • What's Happening: The company's shares jumped around 54% over the past month.
  • What Liberty Star Uranium & Metals Does: Liberty Star Uranium & Metals Corp is an Arizona-based mineral exploration company. It is engaged in the acquisition, exploration, and development of mineral properties in Arizona and the southwest USA.
  • 行業: 自由之星鈾金屬公司(場外交易代碼:LBSR)總裁和首席執行官佈雷特·格羅斯以0.27美元的平均價格收購了總計1395379股。收購這些股份的成本為375,356.95美元。
  • 正在發生的事情:該公司的股價在過去一個月裡上漲了約54%。
  • Liberty Star鈾礦和金屬公司的業務:Liberty Star鈾礦公司是一家總部位於亞利桑那州的礦產勘探公司。該公司在亞利桑那州和美國西南部從事礦產資產的收購、勘探和開發。

Creatd

創建

  • The Trade: Creatd, Inc. (NASDAQ:CRTD) Co-Chief Executive Officer Jeremy Frommer acquired a total of 3251 shares at an average price of $2.00. The insider spent $6,509.56 to buy those shares.
  • What's Happening: The company's stock dropped around 43% over the previous six months.
  • What Creatd Does: Creatd Inc empowers creators, brands, and entrepreneurs through technology and partnership. The company has three platforms, namely Vocal Ventures, Creatd Partners, and Recreatd. Its flagship technology platform is Vocal, which provides creators of all shapes and sizes, from bloggers to podcasters, and more with best-in-class storytelling tools, safe and curated communities, and the opportunity to monetize their content.
  • 《貿易》Creatd公司納斯達克(Sequoia Capital:CRTD)聯席首席執行官傑裡米·弗羅默以2美元的平均價格收購了總計3,251股。這位內部人士花了6509.56美元購買了這些股票。
  • 發生了什麼事?:該公司的股票在過去六個月裡下跌了約43%。
  • Creatd做了什麼:Creatd Inc.通過技術和合作夥伴關係賦予創作者、品牌和企業家權力。該公司有三個平臺,即Voice Ventures、Creatd Partners和Recreatd。它的旗艦技術平臺是Voice,為從部落客作者到播客的各種形狀和規模的創作者,以及更多的人提供一流的講故事工具、安全和精心策劃的社區,以及將其內容貨幣化的機會。

Akerna

阿克爾納

  • The Trade: Akerna Corp. (NASDAQ:KERN) Chief Operating Officer Cecil Ray Thompson Jr acquired a total of 6120 shares at an average price of $2.23. To acquire these shares, it cost $2,499.70. The insider also sold a total of 1230 shares.
  • What's Happening: The company's shares declined around 14% since the start of the year.
  • What Akerna Does: Akerna Corp is a United States-based company. The firm is the first compliance technology company in the cannabis space.
  • 《貿易》阿科爾納公司納斯達克(Sequoia Capital:KERN)首席運營官小塞西爾·雷·湯普森以2.23美元的平均價格收購了總計6,120股票。收購這些股份的成本為2,499.70美元。該內幕人士還出售了總計1,230股股票。
  • 發生了什麼事?自今年年初以來,該公司的股價下跌了約14%。
  • 阿克爾納做了什麼:Akerna Corp是一家總部位於美國的公司。該公司是大麻領域第一家合規技術公司。

Avalo Therapeutics

阿瓦洛治療公司

  • The Trade: Avalo Therapeutics, Inc. (NASDAQ:AVTX) Director Steven Boyd acquired a total of 455000 shares at an average price of $1.00. The insider spent $452,767.93 to buy those shares.
  • What's Happening: Avalo Therapeutics recently reported Phase 1b results for AVTX-002 in moderate to severe Crohn's disease patients and presented additional program updates at the 2022 investor event.
  • What Avalo Therapeutics Does: Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
  • 《貿易》Avalo治療公司(納斯達克股票代碼:AVTX)董事史蒂文·博伊德以1美元的平均價格收購了總計455000股票。這位內部人士花了452,767.93美元購買了這些股票。
  • 發生了什麼事?:Avalo Treateutics最近報告了AVTX-002在中到重度克羅恩病患者中的1b階段結果,並在2022年投資者活動上公佈了額外的計劃更新。
  • Avalo治療公司是做什麼的:Avalo治療公司是一家臨床階段的精密藥物公司,為在免疫學、免疫腫瘤學和罕見遺傳病方面有重大未滿足臨床需求的患者發現、開發和商業化靶向治療。

IronNet

鐵網

  • The Trade: IronNet, Inc. (NYSE:IRNT) Director Michael Rogers acquired a total of 13297 shares at an average price of $3.50. The insider spent $ $46,539.50 to buy those shares.
  • What's Happening: IronNet reported expansion of partnership with New York Power Authority to defend key supply chain partners with collective defense.
  • What IronNet Does: IronNet Inc is a global cybersecurity leader that is transforming how organizations secure their networks by delivering the first-ever Collective Defense platform operating at scale.
  • 《貿易》鐵網,Inc.(紐約證券交易所代碼:IRNT)董事邁克爾·羅傑斯以3.5美元的平均價格收購了總計13297股。這位內部人士花了46,539.50美元購買了這些股票。
  • 發生了什麼事?:IronNet報告擴大了與紐約電力局的合作夥伴關係,以集體防禦保護關鍵供應鏈合作夥伴。
  • IronNet做了什麼:IronNet Inc.是一家全球網路安全領導者,通過提供有史以來第一個大規模運營的集體防禦平臺,該公司正在改變組織保護其網路的方式。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論